Although MYC was predicted as a cancer reversion target, its single inhibition does not significantly alter the size or width of the cancer attractor and, consequently, does not substantially reduce the cancer score (Figure S9b, middle, Supporting Information). The gene discussed is MYC; the disease is cancer.